{
  "docId": "019dd923-622c-750b-8b9a-ad0811d3e80d",
  "docSlug": "dfcef8f28a20",
  "documentTitle": "Accelerate Diagnostics (AXDX)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-09-16 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 9,
  "pageCount": 41,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a Q&A format to present anecdotal evidence from industry reps and a physician to challenge the market value of rapid diagnostic systems.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-ad0811d3e80d/9",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-ad0811d3e80d#slide-9",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "At the price of $200 per reagent kit, Pheno is substantially adding to the reagent cost, not saving!",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b3a2-a392bb6f7db6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.11,
        "y": 0.33
      },
      "kind": "list",
      "text": "Q. How are you different from Pheno system? A. We have a similar approach. We have taken away ID, because many labs in Europe have already invested in MALDI and that solution is good. So we can reduce the price of our product.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "735689de-fc53-4381-8148-fddb99bf31a4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.8,
        "x": 0.11,
        "y": 0.61
      },
      "kind": "list",
      "text": "Q: Why are Accelerate Diagnostics, T2 Biosystems and other rapid diagnostic companies struggling to get their system adopted at the hospitals? A: If you go to a physician and tell him: would you like it if I give you information on what pathogen is present in the blood stream much faster? The Physician would answer - sure, I'd like that. But if you ask him a different question: how often would this",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d72d6af3-8ba3-4edb-81c2-9a37d6fa379e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.11,
        "y": 0.24
      },
      "kind": "paragraph",
      "text": "At the price of $200 per reagent kit, Pheno is substantially adding to the reagent cost, not saving! We are not sure how much more expense ID testing adds to PhenoTest, but the other companies, developing new rapid AST test, are concerned about cost reduction and are not including ID in their design.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34094919-4372-4691-b9b7-64133cefb57f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.11,
        "y": 0.09
      },
      "kind": "paragraph",
      "text": "diagnostic test, called MALDI, is broadly advancing into labs in the US and internationally. At ECCMID 2019, the companies developing next generation of rapid AST testing, told us that MALDI is the new standard for the rapid ID and it does it much cheaper, than Pheno system. As shown in this article, the use of MALDI realized a net savings in reagent costs of 88% compared to traditional methods.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7c098641-ff44-4e34-8419-68b86741ea99",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.8,
        "x": 0.11,
        "y": 0.55
      },
      "kind": "paragraph",
      "text": "We spoke to a former practicing physician, who focused on critical care and was working in an Emergency Care Unit. Here is his view on the problem:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "81b46322-c2b6-457b-859b-ab9ee22930fd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "We have a similar approach. We have taken away ID, because many labs in Europe have already invested in MALDI and that solution is good. So we can reduce the price of our product. — Qlinea rep",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-78b4-70ad-b3a2-a7597b94efd9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.11,
        "y": 0.45
      },
      "kind": "title",
      "text": "The criticality of AST testing for blood infection is over-hyped: physicians seldom use ID and AST data to adjust their treatment of sepsis",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21cafdd2-996e-45e1-b269-38882e30b90d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "9c9c96b1-2d38-455e-822c-8599b2a4dd32",
      "evidence": "The slide frames the Pheno system as a high-cost, potentially unnecessary competitor to the industry-standard MALDI.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 9,
      "from": 3,
      "beatId": "c35db6aa-1659-4676-9230-380b8888605a",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The document highlights several issues with the Pheno system, including its narrow coverage of microorganisms and antibiotics, contamination risks, and the over-hyped criticality of AST testing for blood infection.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 5,
      "name": "Zoom In",
      "slug": "06-zoom-in",
      "bestFor": "Technical deep-dives, case studies, detailed analysis",
      "matchId": "4b8bad5d-bf36-4c0a-9c1e-2294d891556c",
      "evidence": "The document zooms in on several specific limitations of the Pheno system, including its narrow coverage of microorganisms and antibiotics.",
      "position": 0,
      "objective": "What are the limitations of the Pheno system?",
      "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication",
      "confidence": 0.8,
      "description": "Start broad, then progressively focus on specific details that prove your point"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}